[Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer].

Zapata, E

[Prolonged response with paclitaxel after immunotherapy by pembrolizumab in lung cancer]. [electronic resource] - Revue de pneumologie clinique Oct 2016 - 300-304 p. digital

Publication Type: Case Reports; Journal Article

1776-2561

10.1016/j.pneumo.2016.05.004 doi


Aged
Antibodies, Monoclonal, Humanized--therapeutic use
Carcinoma, Non-Small-Cell Lung--pathology
Chemotherapy, Adjuvant
Combined Modality Therapy
Female
Humans
Immunotherapy
Lung Neoplasms--pathology
Paclitaxel--therapeutic use
Time Factors
Treatment Outcome